Mechanisms of loss of lean body mass in patients on chronic dialysis?

Blood Purification

Volumn 14, Issue 5, 1996, Pages 388-394

  Dinarello, Charles A ^a   Roubenoff, Ronenn A ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Cytokines; IL 1; IL 6; Inflammation; Malnutrition; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ARTICLE; CALORIC INTAKE; CHRONIC INFLAMMATION; DIALYSIS; ENERGY EXPENDITURE; HUMAN; LEAN BODY WEIGHT; LIPID STORAGE; MALNUTRITION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; WEIGHT REDUCTION;

BIOLOGICAL FACTORS; BODY CONSTITUTION; BODY MASS INDEX; ENERGY INTAKE; HUMANS; MUSCLE PROTEINS; MUSCLES; RENAL DIALYSIS; WEIGHT LOSS;

EID: 0029742620     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170291     Document Type: Article

References (27)

1. Siegel SA. Shealy DJ. Nakada MT, Le J. Woulfc DS, Proben L, Kollias G. Ghraycb J. Vilchck J, Daddona PH: The mouse/human chimeric monoclonal cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Cytokine 1995;7:15-25.
2. Zamir O. Hasselgren PO. O'Brien W. Thompson RC. Fischer JE: Muscle protein breakdown during endo-toxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-lra). Ann Surg 1992:216: 381-385.
3. Clowes GHA., George BC., Villee CA, Saravis CA: Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 1983;308:545-552.
4. Baracos V., Rodemann HP., Dinarel-lo CA, Goldberg AL: Stimulation of muscle protein degradation and prostaglandin E release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 1983:308:553-558.
5. Gutierrez A, Alvestrand A., Wahren J., Bergstrom J: Effect ol'in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney lnt 1990:38: 487-494.
6. Dinarello CA, WoltTSM: The role of interleukin-1 in disease. N Engl J Med 1993:328:106-113.
7. Flores EA, Bistrian BR. Pomposelli JJ. Dinarello CA, Blackburn GL, Istlan NW: Infusion of tumor necrosis factor/cachcctin promotes muscle catabolism in the rat. A synergistic effect with interleukin I. J Clin Invest 1989:83:1614-1622.
8. Goldberg AL. Kcttclhut IC. Furuno K. Fagan JM. Baracos V: Activation of protein breakdown and prostaglandin Ei production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin I or other known monokines. J Clin Invest 1988:81:1378-1383.
9. Kettelhut I.C., Goldberg AL: Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue. J Clin Invest 1988: 81:1384-1389.
10. Moldawcr LL. Svaninger G., Gelin J., Lundholm KG: Interleukin-1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am J Physiol 1987:253:C766-C773.
11. Hcllerstein MK. Meydani SN. Mcy-dani M., Wu K., Dinarello CA: Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest 1989:84:228-235.
12. Moldawer LL, Andersen C., Gelin J., Lundholm KG: Regulation of food intake and hepatic protein synthesis by recombinant derived cytokines. Am J Physiol 1988;254:G450-G456.
13. Zheng H., Fletcher D., Kozak W., Jiang M., Hofmann K, Conn CC., Siszynski D., Grabiec C, Trumbauer MA., Shaw AR., Kostura MJ., Stevens K., Rosen H., North RJ., Chen HY., Tocci MJ, Kluger MJ., Van dcr Ploeg LHT: Resistance to fever induction and impaired acute-phase response in interleukin-1 deficient mice. Immunity 1995. in press.
14. Mandrup-Poulsen T. Zumsteg U. Rcimers J, Pociot F. Morch L. Helk-vist S, Dinarello CA, Nerup J: Involvement of interleukin-1 and in-lcrlcukin-1 antagonist in pancreatic p-cell destruction in insulin-depen-dent diabetes mellitus. Cytokine 1993:5:185-191.
15. Fattori E, Cappelletti M, Costa P. Sellitlo C. C'antoni L, Carelli M. Faggioni R. Fantuzzi G. Ghezzi P. Poli V: Defective inflammatory response in interleukin 6-dcflcicnt mice. J Exp Med 1994:180:1243-1250.
16. Smith JW. Urba WJ. Curti BD. El-wood LJ, Stcis RG. Janik JE, Sharf-man WH. Miller LL. Fenton RG. Conlon KC, Rossio J. Kopp W, Shi-muzut M. Oppenheim JJ. Longo D: The toxic and hematologic elfects of interleukin-1 alpha administered in a phase 1 trial to patients with advanced malignancies. J Clin Oncol 1992;10:1141-1152.
17. Smith JW, Longo D. Alford WG. Janik JE, Sharfman Wl I, Gause BL. Curti BD. Creekmore SP. Holmlund JT. Fenton RG. Sznol M. Miller LL, Shimzu M. Oppenheim JJ. Fiem SJ. Hursev JC. Powers GC. Urba WJ: The effects of treatment with interleukin-1 a on platelet recovery after high-dose carboplat in. N Engl J Med 1993:328:756-761.
18. Coceani F, Lees J, Dinarello CA: Occurrence of interleukin-1 in cerebrospinal fluid of the conscious cat. Brain Res 1988:446:245-250.
19. Dinarello CA. Cannon JG. Mancilla J, Bishai I., Lees J, Coceani F: Interleukin-6 as an endogenous pyrogen: Induction of prostaglandin E in brain but not in peripheral blood mononuclear cells. Brain Res 1991; 562:199-206.
20. Shapiro L, Zhang X-X, Rupp RG. Wolff SM. Dinarello CA: Ciliary neurotrophic factor is an endogenous pyrogen. Proc Natl Acad Sci USA 1993;90:8614-8618.
21. LeMay LG, Ottcmess I.G., Vander AJ., Kluger MJ: In vivo evidence that the rise in plasma IL-6 following injection of a fever-inducing dose of LPS is mediated by II.-I beta. Cytokine 1990:2:199-204.
22. Mrosovsky N., Molony LA., Conn CA., Kluger MJ: Anorexic effects of interleukin-1 in the rat. Am J Physiol 1989; 257:R 1315-R1321.
23. Wogensen LD., Mandrup-Poulsen T., Markholst H., Molvig J., Lcrnmark A., Holst JJ., Dinarello CA, Nerup J; Interleukin-1 potentiates glucose stimulated insulin release in the isolated perfused pancreas. Acta Endocrinol (Copenh) 1988:117:302-306.
24. Bird TA, Davies T. Baldwin SA, Saklatvala J: Interleukin-1 stimulates hexosc transport in fibroblasts by increasing the expression of glucose transporters. J BiolChem 1990: 265:13578-13583.
25. Gershenwald JE., Fong YM., Fahey TJ., Calvano SE., Chizzonite R., Kil-ian PL., Lowry SF, Moldawcr LL: Intcrleukin-I receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci USA 1990;87:4966-4970.
26. Pereira BJG. King AJ. Falagas ME. Dinarello CA: Interleukin-1 receptor antagonist: An index of dialysis-induced interleukin-1 production. Nephron 1994:67:358-361.
27. Roubcnoff R., Roubcnoft RA., Cannon JG, Kehayias JJ., Zhuang I.I., Dawson-Hughes B. Dinarello CA., Rosenberg IH: Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379-2386.